423 studies found for:
leukemia [CONDITION] AND child [AGE-GROUP] | Open Studies
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
|
||||
| 2 | Recruiting |
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing an Umbilical Cord Blood Transplant for Hematologic Cancer
|
||||
| 3 | Recruiting |
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
|
||||
| 4 | Recruiting |
Cord Blood Transplant
|
||||
| 5 | Recruiting |
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
|
||||
| 6 | Recruiting |
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
|
||||
| 7 | Recruiting |
Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies
|
||||
| 8 | Recruiting |
Improving Blood Stem Cell Collection and Transplant Procedures
|
||||
| 9 | Recruiting |
Stem Cell Transplant for Hematological Malignancy
|
||||
| 10 | Recruiting |
Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer
|
||||
| 11 | Recruiting |
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
|
||||
| 12 | Not yet recruiting |
MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
|
||||
| 13 | Recruiting |
Identifying Prognostic Factors in Frontline FCR for Patients With Chronic Lymphocytic Leukemia (CLL)
|
||||
| 14 | Recruiting |
Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT
|
||||
| 15 | Unknown † |
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])
|
||||
| 16 | Recruiting |
CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
|
||||
| 17 | Recruiting |
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
|
||||
| 18 | Recruiting |
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant For Hematologic Cancer
|
||||
| 19 | Recruiting |
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
|
||||
| 20 | Recruiting |
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
|
† Indicates status has not been verified in more than two years
